New England Retina Consultants | Retina Research Institute

Research site
3640 Main Street Suite 202A, Springfield, Massachusetts, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


3 of 12
Status: Active
Trial type: Interventional
Funder type: Industry

A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (SIGLEC)

Investigate the Safety, Pharmacokinetics, and Treatment effects of Single and Multi-dose of Intravitreal AVD-104 in participants with geographic atro...

Macular Degeneration
Geographic Atrophy of the Macula
Drug: AVD-104
Drug: Avacincaptad

The goal of this clinical trial is to understand the safety of AXT107 injected suprachoroidally in participants with nAMD. The main question[s] it ai...

Neovascular Age-related Macular Degeneration
Drug: AXT107 Mid Dose
Drug: AXT107 High Dose

This phase 2a trial is a randomized, open-label, parallel-group study in approximately 60 patients with DME to evaluate the efficacy and safety of CU...

Active, not recruiting
Diabetic Macular Edema
Drug: CU06-1004

Trial conditions

Macular Degeneration (7 trials)
Geographic Atrophy (3 trials)
Atrophy (2 trials)
Edema (2 trials)
Macular Edema (2 trials)
Wet Macular Degeneration (2 trials)
Proliferative Vitreoreti... (1 trial)
Retinal Diseases (1 trial)
Retinal Vein Occlusion (1 trial)
Telangiectasis (1 trial)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems